Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer

BACKGROUND/AIMS: The benefit of second-line chemotherapy (SL) after failed first-line chemotherapy (FL) in patients with advanced pancreatic cancer has not yet been established. We evaluated the clinical characteristics affecting the benefits of SL compared to best supportive care (BSC), identified...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Gut Liver
Main Authors: Lee, Jeung Eun, Lee, Hee Seung, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, Bang, Seungmin
Format: Artigo
Jezik:Inglês
Izdano: Editorial Office of Gut and Liver 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6974334/
https://ncbi.nlm.nih.gov/pubmed/30974927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18419
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki